2月9日 - ** Stephens 将工程解决方案提供商艾默生电气EMR.N的目标股价从 145 美元上调至 155 美元，重申 "等权重 "评级
** 新目标价仍比上一交易日收盘价下跌 1.5%
** 斯蒂芬斯指出，近期稳健的订单趋势预示著 26 财年之后的增长势头；将 26 财年调整后每股收益预期从之前的 6.43 美元和 6.99 美元上调至 6.48 美元和 7.02 美元。
** 上周，该公司公布 (link) 第一季度利润增长，并上调了 2026 财年调整后每股收益预测的下限，这主要得益于工业自动化设备的强劲需求。
** 2025 年 EMR 增长 7.1%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.